Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction

• Auteurs principaux: Yongji Wang (Auteur), Yangyang Qi (Auteur), Wenguo Xu (Auteur), Yuansheng Hu (Auteur), Ling Wang (Auteur), Yongpei Yu (Auteur), Zhiwei Jiang (Auteur), Jielai Xia (Auteur), Gang Zeng (Auteur), Yalong Wang (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2020-10-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: Hepatitis A vaccine has been used in mass and routine public vaccination programs in China. Long-term follow-up studies are required to determine the duration of protection and the need for booster vaccinations. Methods: A prospective, randomized, open-label clinical trial was performed...